Dr. Steven Fruchtman is a hematologist with extensive industry experience in clinical research for myelodysplastic syndromes, hematologic malignancies and solid tumors. He is an author of more than 170 lectures, presentations, books, and chapters. Previously, Dr. Fruchtman served as the Director of the Myeloproliferative Disorder Program at Mt. Sinai Hospital in New York City and established the Stem Cell Transplant Program there. Dr. Fruchtman currently serves as President, Chief Executive Officer and Director at Onconova Therapeutics, Inc. in Pennsylvania. He is also on the board of The Bone Marrow Foundation.
